most effective glp-1 clinical trials outcomes trends 2025: real-world data, patient & future therapies GLP1 agonists: current and future

Personal dosing (also known as microdosing) GLP-1 medications during menopause involves using sub-clinical doses to manage weight while minimizing side effects

Research shows a 40-fold increase in these drugs from 2017 to 2021, estimating that roughly 2-3% of the United States is now on either Ozempic or Mounjaro

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved cardiovascular biomarkers, a small retrospective study indicated.

Insulinogenic index (IGI) and whole-body insulin sensitivity were calculated using glucose and insulin levels from the OGTT

Protein Support for Muscle & Strength: Complete protein with BCAAs helps support lean muscle, strength, and recovery

Understand how to get it and whats changing this year.